+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Urinary Tract Infection Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5328163
  • Report
  • September 2020
  • Region: Global
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Allecra Therapeutics
  • Bayer AG
  • Cipla Ltd.
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer Inc.
  • MORE
Urinary Tract Infection (UTI) is caused when bacteria enters the urethra and infects the urinary bladder, causing severe health issues. UTI infections are common health problems in females than in males with biologic factors accounting as the major cause. Antibiotics are usually the first line of treatment prescribed by doctors for urinary tract infections. According to the site of manifestation by the microbe, infections are classified as cystitis (bladder), urethritis (urethra), prostatitis (prostate) or pyelonephritis (kidney). Painful and increased frequency of urination, excessive and involuntary passing of urine at night are the common symptoms associated with UTI. Hospitalized patients using urinary catheters are at a higher risk for developing UTI.

Restraints of the Global Urinary Tract Infection Treatment Market

Major factors hampering the growth of the urinary tract infection treatment market during the forecast period constitutes of low adoption of internet in some emerging economies.

Key features of the study:
  • This report provides in-depth analysis of the global urinary tract infection treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global urinary tract infection treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Cipla Ltd., Johnson & Johnson, Bayer AG, Pfizer Inc., GlaxoSmithKline, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd., Iterum Therapeutics plc, Novartis AG AstraZeneca Plc, Allecra Therapeutics, Healthy.io, Shionogi Inc., Spero Therapeutics, Inc., and Venatorx Pharmaceuticals.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global urinary tract infection treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation

Global Urinary Tract Infection Treatment Market, By Drug Type:
  • Penicillin & Combinations
  • Amoxicillin
  • "Amoxicillin+ Clavulanate
  • Potassium"
  • Others
  • Quinolones
  • Ciprofloxacin
  • Levofloxacin
  • Nalidixic acid
  • Norfloxacin
  • Others
  • Cephalosporin
  • Ceftriaxone
  • Cefuroxime
  • Cefixime
  • Cephalexin
  • Aminoglycoside Antibiotics
  • Amikacin
  • Gentamicin
  • "Sulphonamides (Sulfamethoxazole +
  • Trimethoprim)"
  • Azoles and Amphotericin B
  • Tetracycline (Doxycycline)
  • Nitrofurans (Nitrofurantoin)
  • Other
Global Urinary Tract Infection Treatment Market, By Disease Indication:
  • Complicated UTI
  • Recurring Complicated UTI
  • Uncomplicated UTI
  • Neurogenic Bladder Infections
Global Urinary Tract Infection Treatment Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Global Urinary Tract Infection Treatment Market, By Geography:
  • North America
By Country:
  • U.S.
  • Canada
  • Europe
By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
o Middle East:

By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Cipla Ltd.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Johnson & Johnson
  • Bayer AG
  • Pfizer Inc.
  • GlaxoSmithKline
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche Ltd.
  • Iterum Therapeutics plc
  • Novartis AG
  • AstraZeneca Plc
  • Allecra Therapeutics
  • Shionogi Inc.
  • Spero Therapeutics, Inc.
  • Venatorx Pharmaceuticals.
“*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allecra Therapeutics
  • Bayer AG
  • Cipla Ltd.
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer Inc.
  • MORE
1. Research Objective and Assumption
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Disease Indication
  • Market Snippet, By Distribution Channel
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • COVID-19 Impact Analysis
4. Global Urinary Tract Infection Treatment Market, By Drug Type, 2019 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • Penicillin & Combinations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
  • Amoxicillin
  • Amoxicillin+ Clavulanate
  • Potassium"
  • Others
  • Quinolones
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
  • Ciprofloxacin
  • Levofloxacin
  • Nalidixic acid
  • Norfloxacin
  • Others
  • Cephalosporin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
  • Ceftriaxone
  • Cefuroxime
  • Cefixime
  • Cephalexin
  • Aminoglycoside Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
  • Amikacin
  • Gentamicin
  • "Sulphonamides (Sulfamethoxazole +
  • Trimethoprim)"
  • Azoles and Amphotericin B
  • Tetracycline (Doxycycline)
  • Nitrofurans (Nitrofurantoin)
  • Other
5. Global Urinary Tract Infection Treatment Market, By Disease Indication, 2019 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • Complicated UTI
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Recurring Complicated UTI
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Uncomplicated UTI
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Neurogenic Bladder Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
6. Global Urinary Tract Infection Treatment Market, By Distribution Channel, 2019 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
7. Global Urinary Tract Infection Treatment Market, By Regions, 2019 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • U.S.
  • Canada
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa
8. Competitive Landscape
  • Company Profiles
  • Cipla Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Bayer AG
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • GlaxoSmithKline
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Boehringer Ingelheim
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Iterum Therapeutics plc
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Novartis AG
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • AstraZeneca Plc
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Allecra Therapeutics
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Shionogi Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Spero Therapeutics, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Venatorx Pharmaceuticals.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
9. Section
  • References
  • Research Methodology
  • About us and Sales Contact
Note: Product cover images may vary from those shown
  • Cipla Ltd.
  • Johnson & Johnson
  • Bayer AG
  • Pfizer Inc.
  • GlaxoSmithKline
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche Ltd.
  • Iterum Therapeutics plc
  • Novartis AG
  • AstraZeneca Plc
  • Allecra Therapeutics
  • Shionogi Inc.
  • Spero Therapeutics, Inc.
  • Venatorx Pharmaceuticals.
Note: Product cover images may vary from those shown
Adroll
adroll